- All sections
- C - Chemistry; metallurgy
- C07D - Heterocyclic compounds
- C07D 207/26 - 2-Pyrrolidones
Patent holdings for IPC class C07D 207/26
Total number of patents in this class: 348
10-year publication summary
|
26
|
20
|
24
|
17
|
21
|
16
|
18
|
24
|
19
|
9
|
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| University of Southern California | 2016 |
13 |
| Novartis AG | 11238 |
11 |
| Cayman Chemical Company, Incorporated | 72 |
10 |
| Pfizer Inc. | 3322 |
8 |
| California Institute of Technology | 3884 |
8 |
| F. Hoffmann-La Roche AG | 7958 |
7 |
| BASF SE | 19740 |
7 |
| UCB Pharma S.A. | 280 |
6 |
| Servier Pharmaceuticals, LLC | 95 |
6 |
| Allergan, Inc. | 2600 |
5 |
| Glaxosmithkline Intellectual Property Development Limited | 723 |
5 |
| Takeda Pharmaceutical Company Limited | 2961 |
5 |
| Theravance Biopharma R&D IP, LLC | 550 |
5 |
| Merck & Co., Inc. | 607 |
4 |
| FMC Corporation | 910 |
4 |
| HAPLOGEN GmbH | 9 |
4 |
| OPKO Health, Inc. | 52 |
4 |
| PTC Therapeutics, Inc. | 492 |
4 |
| Richter Gedeon Nyrt. | 1534 |
4 |
| The Scripps Research Institute | 1364 |
4 |
| Other owners | 224 |